Sending you love, hugs and understanding
-
Don't miss the opportunity to attend Tinnitus Quest's online Q&A with Dr. Susan Shore and Jon Pearson, CEO of Auricle on October 13. We will hear the latest about the Susan Shore Device.
➡️ Details & Registration!
Tinnitus Talk Support Forum
@Daniel Lion I really appreciate that gesture.
What did you want to know about XEN1101, @SarahMLFlemmer?
@Damocles Hi! IDK exactly. What does it do? When is it expected to start trials and what not?
Without going into great detail, XEN1101 is basically an improved version of Retigabine/Trobalt; a discontinued epilepsy medication that some members of TT experimented with back in 2014.
The self-experiments garnered some positive results, but were also, unfortunately, accompanied by many nasty side effects.
The self-experiments garnered some positive results, but were also, unfortunately, accompanied by many nasty side effects.
The idea is that the reformulation of said Retigabine will provide the same positive results, but without the deleterious effects.
As for ETA, the drug has made it to, and is currently in, Phase 3 trials (a good sign), the data for which should be available by 2025/26.
As for ETA, the drug has made it to, and is currently in, Phase 3 trials (a good sign), the data for which should be available by 2025/26.
@Damocles Thanks for the info! What kind of side effects were there, do you know?
2025, 2026 seems so far away. Lol.
2025, 2026 seems so far away. Lol.